Frequency and carrier risk associated with common BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer patients - Wikidata - wikimedia - TriplyDB

Frequency and carrier risk associated with common BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer patients

Frequency and carrier risk associated with common BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer patients

http://www.wikidata.org/entity/Q24170410

about

Localization of BRCA1 protein in breast cancer tissue and cell lines with mutations Maple syrup urine disease: identification and carrier-frequency determination of a novel founder mutation in the Ashkenazi Jewish population.Breast cancer mortality among Ashkenazi Jewish women in São Paulo and Porto Alegre, Brazil Log odds of carrying an Ancestral Mutation in BRCA1 or BRCA2 for a Defined personal and family history in an Ashkenazi Jewish woman (LAMBDA)Bias Correction Methods Explain Much of the Variation Seen in Breast Cancer Risks of BRCA1/2 Mutation Carriers Examining the pathogenesis of breast cancer using a novel agent-based model of mammary ductal epithelium dynamics Genetics through a primary care lens.Why should primary care physicians know about breast cancer genetics?Population-Calibrated Gene Characterization: Estimating Age at Onset Distributions Associated With Cancer Genes Classification of Missense Mutations of Disease Genes Characterization of BRCA1 and BRCA2 mutations in a large United States sample A discrete choice experiment of preferences for genetic counselling among Jewish women seeking cancer genetics services Prevalence of BRCA1 in a hospital-based population of Dutch breast cancer patients A probability model for predicting BRCA1 and BRCA2 mutations in breast and breast-ovarian cancer families Heritable breast cancer in twins Tilting at quixotic trait loci (QTL): an evolutionary perspective on genetic causation Variation in breast cancer risk in BRCA1 and BRCA2 mutation carriers Associations of high-grade prostate cancer with BRCA1 and BRCA2 founder mutations The importance of a family history of breast cancer in predicting the presence of a BRCA mutation A single nucleotide polymorphism in the RAD51 gene modifies cancer risk in BRCA2 but not BRCA1 carriers BRCA1 and BRCA2 testing: weighing the demand against the benefits.The prevalence of common BRCA1 and BRCA2 mutations among Ashkenazi Jews Penetrances of BRCA1 1675delA and 1135insA with respect to breast cancer and ovarian cancer.Prevalence of 185delAG and 5382insC mutations in BRCA1, and 6174delT in BRCA2 in women of Ashkenazi Jewish origin in southern Brazil Cancer evolution and individual susceptibility Prevalence of the most frequent BRCA1 mutations in Polish population Examining the Relationship between Pre-Malignant Breast Lesions, Carcinogenesis and Tumor Evolution in the Mammary Epithelium Using an Agent-Based Model What are genes "for" or where are traits "from"? What is the question?Novel germline mutations in the PTEN tumour suppressor gene found in women with multiple cancers Genetic mapping in mice identifies DMBT1 as a candidate modifier of mammary tumors and breast cancer risk Unravelling genetic data by arrayed primer extension.Clinical management of BRCA1- and BRCA2-associated breast cancer.Involvement of BRCA1 and BRCA2 in breast cancer in a western Finnish sub-population.Pharmacogenetics in clinical practice: considerations for testing.Inherited predisposition and breast cancer: modifiers of BRCA1/2-associated breast cancer risk.Clinical considerations in the management of individuals at risk for hereditary breast and ovarian cancer.Modifiers of risk of hereditary breast and ovarian cancer.The use of gene tests to detect hereditary predisposition to chronic disease: is cost-effectiveness analysis relevant?Common BRCA1 and BRCA2 mutations in breast cancer families: a meta-analysis from systematic review.Candidate Gene Analysis of Breast Cancer in the Jordanian Population of Arab Descent: A Case-Control Study.

P2860

Q24308016-1AA9C092-D653-40C6-A6A1-6423DD75B926 Q24533417-1FDBEB39-7AC3-41B4-8D2C-E9A593DFE6DF Q24800553-8680CA0F-6658-4EB2-867B-C3C0E627B559 Q24802704-D63DD355-20E0-4DAC-A5F1-4F20B6CF0DAB Q28085448-53E160D7-229C-4E99-9824-B165ED8C7CE0 Q28383242-CA597705-EBD4-439C-9AD9-786E1CBC4157 Q28383584-83A7498C-8CC5-462A-9E7E-DEA4736963FC Q28383592-A28ECD2C-54AB-4ECE-87B4-D663C68149F2 Q28383948-32AD6AC6-646D-44CF-88FB-5C87F8CA6ABD Q28383958-30DE2C86-DC1E-4732-ADFF-C65C6375DBF7 Q28383993-532408AF-C7B6-43F8-B966-1F92F9E273BB Q28384136-D076D815-2DDB-40ED-B579-849B8796DB12 Q28384196-4B556E03-C1FB-4796-A87E-D0B383F8EFA9 Q28384206-75E5F78E-42B4-40AB-B305-621DA732F606 Q28384224-44AA75DB-2D19-41C9-9669-1BDB655D1779 Q28385221-FD2E37C3-A57C-4537-B465-605265EB1F0A Q28386156-06E0ADDC-3C78-4B5A-BA53-45925FEB27F5 Q28386233-C9045CAA-82EA-4B90-84CB-2F3A5BBF7394 Q28386650-65A36835-67F3-4FD2-A497-B33F3F87562E Q28387138-C685923C-0389-4D6F-A36B-0F1D4FB6BF1E Q28387366-3A9DAA68-6522-4900-836C-6C63B2D1635B Q28387376-DBEEC30A-1602-4807-A43D-4B83E92F19D8 Q28387387-62E02E3D-540D-444A-9215-AE760094178F Q28389127-16F308DF-56EF-4A2D-A131-2819EE56B1F8 Q28389946-AD8C5010-1E57-428E-9DC4-FA5BD3013EC5 Q28390186-CAF64007-4431-44D5-B045-F246EC20F284 Q28390826-A6989760-A879-4F86-A0CE-E3053381655C Q28393055-0E9A6588-627C-47CE-A767-901811F826E1 Q28393163-905DCD0E-54A1-4F5C-BD4D-A4744BC5F208 Q28396100-613F14D3-5F7D-481F-A5EC-86B2B27E21FF Q30596949-ED7C0F49-44D6-482F-BE91-026E511BF446 Q33915589-026982F7-607F-4333-9859-A002A343637F Q33933643-39DD5BEF-B683-4F46-B522-F89A48BECFD1 Q34499056-E6EF8A61-AD86-4124-9459-36209DA3A102 Q34580741-4184CA00-91C3-49E9-8D58-E8F5F4FCA8B2 Q35039478-6EC66DF4-3763-4EC6-AA6C-861F5AA116A4 Q35084790-EED40CCD-FB80-4427-8DDF-932A26FC20AE Q35564692-C8EAE23F-579B-4236-920A-9BE74989DF91 Q37885224-2EF1A7E3-914C-4A59-8229-1A2904271E09 Q38921045-309E8504-281E-45FE-BB41-8BEAD93B0BE1

P2860

Frequency and carrier risk associated with common BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer patients

http://www.wikidata.org/entity/Q24170410

description

1998 nî lūn-bûn

@nan

1998 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

1998 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

1998年の論文

@ja

1998年論文

@yue

1998年論文

@zh-hant

1998年論文

@zh-hk

1998年論文

@zh-mo

1998年論文

@zh-tw

1998年论文

@wuu

name

Frequency and carrier risk ass ...... Jewish breast cancer patients

@ast

Frequency and carrier risk ass ...... Jewish breast cancer patients

@en

Frequency and carrier risk ass ...... Jewish breast cancer patients

@en-gb

Frequency and carrier risk ass ...... Jewish breast cancer patients

@nl

type

label

Frequency and carrier risk ass ...... Jewish breast cancer patients

@ast

Frequency and carrier risk ass ...... Jewish breast cancer patients

@en

Frequency and carrier risk ass ...... Jewish breast cancer patients

@en-gb

Frequency and carrier risk ass ...... Jewish breast cancer patients

@nl

prefLabel

Frequency and carrier risk ass ...... Jewish breast cancer patients

@ast

Frequency and carrier risk ass ...... Jewish breast cancer patients

@en

Frequency and carrier risk ass ...... Jewish breast cancer patients

@en-gb

Frequency and carrier risk ass ...... Jewish breast cancer patients

@nl

P1433

Q24170410-79152BF6-AFB2-4617-9F9C-91AE44BD0BDF

P1476

Q24170410-931CA43F-FA7E-4C02-BCF1-314C117E4E01

P2093

Q24170410-06A34570-66C7-43F6-9D27-607A6B0E706D

Q24170410-12E5E8C3-D6DE-4166-8899-3DFB4B2CAFDE

Q24170410-18381E6C-8A44-461E-9A5F-9B6C265C447D

Q24170410-37AD5EB2-513B-409D-AE19-7CEC687496FB

Q24170410-756CE48D-A10C-46DB-8CD3-C031B0443998

Q24170410-8F5F0802-48B1-4678-A9C9-AC6C6D1043C6

Q24170410-A208B52F-12C2-411F-BBA7-AC908E8D77D8

Q24170410-CF4E8F18-37C9-467C-BB3B-4F9EB90EBCAB

P2860

Q24170410-025B6BB4-CB3A-42D0-9425-EAC9EBA217BA

Q24170410-2C4014F5-137B-43A0-9208-517AE15C386C

Q24170410-2D018177-A218-4FCB-AF9C-C823E573EB2E

Q24170410-2E4ED1DC-DED3-413A-ABFA-5AD59CF0D996

Q24170410-361A7417-15B3-4CF1-929F-22989C9D2D1A

Q24170410-4CB112DE-9FD5-475E-B232-83B27DF7D3B2

Q24170410-5C41E416-4D25-4D05-B7E2-75159250324A

Q24170410-6135D656-F5BB-4233-A7C9-38D8767025BD

Q24170410-72ADBAF6-9928-4B78-AB19-7197AC2CB8BB

Q24170410-83378F08-60F5-44BD-8B0F-E14B4D4AFB6B

P2880

Q24170410-3C4BDD89-87E5-4C44-943A-B928AFD3E4BD

P304

Q24170410-A0442EF3-7C14-408B-BB3D-4B28AB3CFDF4

P31

Q24170410-F575D140-7FDD-4484-A9C1-CC5C9EF9F213

P3181

Q24170410-0409424D-58CE-465D-A9E2-D05CC187FD96

P356

Q24170410-3BCC92E7-6C9D-49B4-A957-CD29D43E3DBC

P407

Q24170410-9DBDBF34-9B9E-4EAD-90F1-471DE08C467C

P433

Q24170410-F228F44C-8E16-4EC5-824C-31D63A9750EE

P478

Q24170410-9E4F5D82-BAAB-4F06-85A6-3503465E7C9D

P577

Q24170410-A64CEE55-951D-4208-A89B-4E4F5FF49096

P5875

Q24170410-33894DBC-42F5-4B46-BABF-AD5F25A121C3

P698

Q24170410-912F8036-876C-4EFB-859F-57E8997317DF

P859

Q24170410-B46FDECE-51D6-41A4-9BE7-FA9B991F711A

P921

Q24170410-222D4C71-444E-4C09-855D-9C56F5685B15

Q24170410-54E6D966-93FB-4FF1-8029-CD9D3D0AE936

Q24170410-5DCF3D9B-6E60-4902-9A35-F47FAC736323

Q24170410-9A805E04-4BC6-45FB-8B0C-52E0C5C3A046

Q24170410-A04CA55D-8AD2-4DD6-AF63-89902B40F56D

P932

Q24170410-5C849EA7-E979-418A-92AA-C94F8744E11B

P3181

P356

P1433

American Journal of Human Genetics

P1476

Frequency and carrier risk ass ...... Jewish breast cancer patients

@en

P2093

A Weston

http://www.w3.org/2001/XMLSchema#string

C M Eng

http://www.w3.org/2001/XMLSchema#string

F H Fodor

http://www.w3.org/2001/XMLSchema#string

I J Bleiweiss

http://www.w3.org/2001/XMLSchema#string

L D McCurdy

http://www.w3.org/2001/XMLSchema#string

M M Walsh

http://www.w3.org/2001/XMLSchema#string

P I Tartter

http://www.w3.org/2001/XMLSchema#string

S T Brower

http://www.w3.org/2001/XMLSchema#string

P2860

BRCA1 mutations in Ashkenazi Jewish women

Novel inherited mutations and variable expressivity of BRCA1 alleles, including the founder mutation 185delAG in Ashkenazi Jewish families

The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews

The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals.

Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families.

Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13.

Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer.

Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.

Genetic analysis of breast cancer in the cancer and steroid hormone study

The founder mutations 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60% of ovarian cancer and 30% of early-onset breast cancer patients among Ashkenazi women.

P2880

20025286

http://www.w3.org/2001/XMLSchema#string

P304

45-51

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

5022798

http://www.w3.org/2001/XMLSchema#string

P356

10.1086/301903

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

63

http://www.w3.org/2001/XMLSchema#string

P577

1998-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

13649133

http://www.w3.org/2001/XMLSchema#string

P698

9634504

http://www.w3.org/2001/XMLSchema#string

P859

National Institute for Occupational Safety and Health

P921

race and health

P932

1377227

http://www.w3.org/2001/XMLSchema#string